Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06131411
Other study ID # DIABETHIC
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 7, 2023
Est. completion date April 30, 2025

Study information

Verified date November 2023
Source Azienda Ospedaliero-Universitaria Careggi
Contact Pietro A Modesti, MD, PhD
Phone 055 7949376
Email pa.modesti@unifi.it
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to evaluate the efficacy of the co-created, culture-sensitive intervention to promote healthy diet, physical activity, and to improve compliance to therapeutic protocols in immigrants with type 2 diabetes.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date April 30, 2025
Est. primary completion date March 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Immigrant status: Self-identification of being born in High migration pressure countries from parents born in High migration pressure countries - Age = 18 years - Type 2 diabetes newly diagnosed or with HbA1c > 8% in the last assessment within 24 months before the visit Exclusion Criteria: - Patients who will not provide the informed consent - Patients with HbA1c = 8% in the last assessment within 24 months before the visit - Severe psychiatric disorders - Pregnant women - Critical illness - Impaired cognitive or physical ability that could make the intervention not feasible, as judged by clinical staff members

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Health promotion
Co-created culture-tailored intervention of health promotion aimed to increase healthy diet, physical activity and compliance with treatment protocols for diabetes.
Usual care
Health promotion activities routinely performed by Diabetes clinics at the recruiting centres.

Locations

Country Name City State
Italy Azienda Ospedaliera Universitaria Renato Dulbecco Catanzaro
Italy Azienda Ospedaliera-Universitaria Careggi Florence
Italy AUSL - IRCCS in Tecnologie Avanzate e Modelli Assistenziali in Oncologia di Reggio Emilia Reggio Emilia
Italy Istituto Nazionale per la promozione della salute delle popolazioni Migranti e il contrasto delle malattie della Povertà (INMP) Rome

Sponsors (4)

Lead Sponsor Collaborator
Azienda Ospedaliero-Universitaria Careggi AUSL - IRCCS in Tecnologie Avanzate e Modelli Assistenziali in Oncologia di Reggio Emilia, Azienda Ospedaliera Universitaria Renato Dulbecco, Istituto Nazionale per la promozione della salute delle popolazioni Migranti e per il contrasto delle malattie della Povertà (INMP)

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Glycated haemoglobin (HbA1c) Change in glycated haemoglobin (HbA1c) from baseline to follow-up at month 12
Secondary Systolic Blood Pressure Change in Systolic Blood Pressure from baseline to follow-up at month 12
Secondary Diastolic Blood Pressure Change in Diastolic Blood Pressure from baseline to follow-up at month 12
Secondary Total Cholesterol Change in Total Cholesterol from baseline to follow-up at month 12
Secondary LDL Cholesterol Change in LDL Cholesterol from baseline to follow-up at month 12
Secondary HDL Cholesterol Change in HDL Cholesterol from baseline to follow-up at month 12
Secondary Triglycerides Change in triglycerides from baseline to follow-up at month 12
Secondary Body Mass Index (BMI) Change in Body Mass Index (BMI) from baseline to follow-up at month 12
Secondary Waist circumference Change in Waist circumference from baseline to follow-up at month 12
Secondary Physical activity Change in compliance with World Health Organization recommended exercise goals from baseline to follow-up at month 12
Secondary Adherence to Mediterranean Diet Change in Adherence to Mediterranean Diet from baseline to follow-up at month 12
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2